Eternum Inc. of Shibuya, Tokyo, led by Representative Director Takaaki Matsumoto, will exhibit at Clinic Management Forum in Fukuoka, to be held on Sunday, May 17, 2026, at Daimyo Conference. The company’s mission is to “create a future where the dream of eternal beauty does not end as just a dream.” At the event, Eternum will propose the potential of next-generation treatments and products that apply insights from regenerative medicine, under the theme of sustainable growth and higher added value in aesthetic medicine. The company will display and sell a range of products, including the medical institution-exclusive Eternum DR series and a topical lip serum highly formulated with human umbilical cord-derived mesenchymal stem cell culture supernatant. At the booth, Eternum will also introduce its formulation design focused on cellular activity, support programs for clinics adopting the products, and education, sales promotion, and marketing support. Visitor benefits include 20% off all products, an Eternum DR mini trial set for completing a questionnaire, 10 Eternum DR mini trial sets for confirming a business meeting appointment on site, and a sample of the visitor’s choice for following the official Instagram account or adding the brand on LINE. Individually sold facial mask sheets are excluded from the discount. The mini trial set includes skincare and lip serum samples. Eternum DR is a skincare series exclusively sold through medical institutions and developed from research in regenerative medicine. It uses advanced umbilical cord-derived stem cells and a formulation incorporating exosomes and cytokines to help achieve “timeless skin,” defined as skin with firmness and radiance through moisture. Eternum is recruiting medical institutions of all types to carry Eternum DR and welcomes clinics seeking to offer next-generation regenerative beauty. Special consultation sessions for product introduction will be available during the event. The event will be held from 1